Strides Shasun gets USFDA nod for altitude sickness tablets Ruby Khatun Khatun23 Nov 2017 5:00 AM GMTBangalore: Strides Shasun Limited announced that it's wholly owned subsidiary Strides Pharma Global Pte. Ltd. has received approval from the United...
Eris, Strides Shasun shares gain up to 7 percent on Rs 500 crore deal Ruby Khatun Khatun22 Nov 2017 5:15 AM GMTNew Delhi: Shares of Eris Lifesciences and Strides Shasun rose by as much as 7 percent after both the companies entered into a definitive pact to buy...
Eris Life Sciences to acquire Strides India branded formulation business for Rs 500 crore: Report Ruby Khatun Khatun18 Nov 2017 11:01 AM GMTMUMBAI: Eris Life Sciences is going to acquire Stride Shasun India branded formulations business as the company has agreed to sell it for Rs 500 crore ...
Strides Shasun gets USFDA nod for lipid lowering drug Ruby Khatun Khatun21 Sep 2017 5:19 AM GMTNew Delhi: Drug firm Strides Shasun on Wednesday said it has received approval from the United States health regulator for generic Omega-3-acid ethyl...
Strides Shasun gets USFDA nod for kidney stone tablets Ruby Khatun Khatun13 Sep 2017 8:11 AM GMTNew Delhi: Strides Shasun on Tuesday said it has received approval from the US health regulator for potassium citrate extended release tablets used to ...
